PR Distribution Report [070720257994965112550829000]

v.3.517

TABLE OF CONTENT
1) Table of content
2) Summary
3) Report details
4) Where did we publish on, release via and submit to…
5) Who did we target, where and how…
6) Who did we reach out to…
7) Who engaged…
8) Insights…
9) Extend…
REPORT SUMMARY
Overview: Between July 7–17, 2025, the English-language release “Aortic Aneurysms: EU-funded Pandora Project…” ran on EuropaWire with a €299 distribution budget, generating 46 820 total title views (27 092 targeted) at €0.0063 per view, driving 1 319 qualified reads (2.81% read-rate) at €0.22 per read, reaching 26 552 combined social-media followers at €0.011 per follower and 200+ high-profile influencers at €0.495 each, and sparking 8 shares, 248 likes, 6 Pinterest saves, 6 Flipboard interactions, plus 1 reaction and 1 third-party mention with 256 engagements in overall.
REPORT DETAILS
PR Distribution Report ID: 070720257994965112550829000
PR Distribution Campaign ID: 7994965112550829000
Customer: stanculescud@gmail.com
Email for Contacts: stanculescu.media@gmail.com
Press Release: Aortic Aneurysms: EU-funded Pandora Project Brings In-Silico Modelling to Aid Surgeons link opens in a new window
Newsroom: Pandora Project
Press Release language: English
PR released on: Jul 7, 2025
Report started on: Jul 7, 2025
Report last updated on: Jul 17, 2025*

* Frequent updates on your PR distribution report are only done during the active period of your PR campaign. Further updates on this PR distribution report beyond the PR campaign period may be done on an irregular basis. You’ll be notified via an email if such an update has been made in future on your PR distribution report.
PR campaign duration:
The campaign duration depends on the PR distribution budget.
(Jul 7, 2025 – Jul 17, 2025 ~ 11 days)
Is PR campaign active?
The active period of your PR distribution campaign depends on the PR distribution budget.
No. The active period of your PR distribution campaign is over*.

Extend PR campaign & reach?

* Even if the active period of your PR distribution campaign is over, your press release remains alive and is up and running on EuropaWire and all the places it has been published on, released via, submitted to and appeared on. The active period of your PR distribution campaign depends on the PR distribution budget and can be anything between one week and 30+ days if larger PR distribution budgets are used. During the active period of your PR distribution campaign, EuropaWire uses its news-wire platform and market insights to proactively engage in leveraging some of today’s most sophisticated and precise multi-channel targeting options available online to source and reach out to the audience that might be interested in and engage with your PR message based on your targeting preferences. The larger the PR distribution budget the longer both the PR distribution campaign and the observed period covered by your PR distribution report.
PR report observed period:
The observed period for the PR distribution report depends on the PR distribution campaign duration.
(Jul 7, 2025 – Jul 17, 2025 ~ 11 days)*

*The observed period for the PR distribution report is tied up with the PR distribution budget used and covers the active period of your PR distribution campaign. The larger the PR distribution budget the longer both the PR distribution campaign and the observed period covered by your PR distribution report.
Report in progress: No
Report is completed: Yes
PR distribution budget: €299
Total reach: 46,820+ (Jul 7, 2025 – Jul 17, 2025 ~ 11 days)
Reach level:
Indicates how optimal your reach is versus the average for the PR distribution budget employed.
Reach level~26.1%*

* Please note that while this indicator looks into how your reach performed towards the average for the same PR budget, targeting different countries, markets and audiences usually results in significantly different reach level for PR distribution campaigns with the same PR budgets.
WHERE DID WE PUBLISH…
Your press release has been published on, released via, submitted to, and appeared on EuropaWire, the Internet, Web, Search engines, the Blogosphere, News, News aggregators, Social media, etc.
Site URL
EuropaWire: Press release page:

Aortic Aneurysms: EU-funded Pandora Project Brings In-Silico Modelling to Aid Surgeons

Aortic Aneurysms: EU-funded Pandora Project Brings In-Silico Modelling to Aid Surgeons AMP

Categories:

https://europawire.es/markets/artificial-intelligence/
https://europawire.es/markets/european-union/
https://europawire.es/markets/france/
https://europawire.es/markets/healthcare/
https://europawire.es/markets/italy/
https://europawire.es/markets/pharma-biotech/
https://europawire.es/markets/science/
https://europawire.es/markets/technology/

Tags:

https://europawire.es/press-releases-tagged-with/3d-models/
https://europawire.es/press-releases-tagged-with/aiincardiology/
https://europawire.es/press-releases-tagged-with/ansys/
https://europawire.es/press-releases-tagged-with/aortic-aneurysms/
https://europawire.es/press-releases-tagged-with/aortic-surgery/
https://europawire.es/press-releases-tagged-with/aorticaneurysm/
https://europawire.es/press-releases-tagged-with/aorticsurgery/
https://europawire.es/press-releases-tagged-with/artificial-intelligence-2/
https://europawire.es/press-releases-tagged-with/b2b2b-approach/
https://europawire.es/press-releases-tagged-with/biomedical-engineer/
https://europawire.es/press-releases-tagged-with/cardiovascular-numerical-simulation/
https://europawire.es/press-releases-tagged-with/cardiovascular-surgery/
https://europawire.es/press-releases-tagged-with/cardiovascularhealth/
https://europawire.es/press-releases-tagged-with/cardiovascularsimulation/
https://europawire.es/press-releases-tagged-with/dacron-prostheses/
https://europawire.es/press-releases-tagged-with/datasets/
https://europawire.es/press-releases-tagged-with/digitalhealth/
https://europawire.es/press-releases-tagged-with/digitaltwin/
https://europawire.es/press-releases-tagged-with/epidemiological-studies/
https://europawire.es/press-releases-tagged-with/eu-funded/
https://europawire.es/press-releases-tagged-with/ffplus-consortium/
https://europawire.es/press-releases-tagged-with/h2020-project/
https://europawire.es/press-releases-tagged-with/horizoneurope/
https://europawire.es/press-releases-tagged-with/hpcinhealthcare/
https://europawire.es/press-releases-tagged-with/in-silico-modelling/
https://europawire.es/press-releases-tagged-with/insa/
https://europawire.es/press-releases-tagged-with/insilicomedicine/
https://europawire.es/press-releases-tagged-with/insilicosurgery/
https://europawire.es/press-releases-tagged-with/institut-national-des-sciences-appliquees/
https://europawire.es/press-releases-tagged-with/leonardo-geronzi-phd/
https://europawire.es/press-releases-tagged-with/livgemini/
https://europawire.es/press-releases-tagged-with/ltsi-laboratory/
https://europawire.es/press-releases-tagged-with/medical-device-manufacturers/
https://europawire.es/press-releases-tagged-with/medical-image-analysis/
https://europawire.es/press-releases-tagged-with/medicalimageanalysis/
https://europawire.es/press-releases-tagged-with/meditate/
https://europawire.es/press-releases-tagged-with/medtechinnovation/
https://europawire.es/press-releases-tagged-with/mesh-morphing-algorithms/
https://europawire.es/press-releases-tagged-with/numericalsimulation/
https://europawire.es/press-releases-tagged-with/pandora/
https://europawire.es/press-releases-tagged-with/pandora-project/
https://europawire.es/press-releases-tagged-with/pandoraproject/
https://europawire.es/press-releases-tagged-with/para-anastomotic-aneurysms/
https://europawire.es/press-releases-tagged-with/post-implant-prosthesis-kinking/
https://europawire.es/press-releases-tagged-with/post-surgery-coronary-perfusion/
https://europawire.es/press-releases-tagged-with/predictive-assessment-of-aortic-surgery-outcomes/
https://europawire.es/press-releases-tagged-with/predictive-tools/
https://europawire.es/press-releases-tagged-with/predictivesurgery/
https://europawire.es/press-releases-tagged-with/prosthesis/
https://europawire.es/press-releases-tagged-with/rbf-morph/
https://europawire.es/press-releases-tagged-with/surgicalplanning/
https://europawire.es/press-releases-tagged-with/universite-de-rennes/
https://europawire.es/press-releases-tagged-with/university-hospital-of-rennes/
https://europawire.es/press-releases-tagged-with/univren/

Google: https://www.google.com/search?hl=en&noj=1
Google News: https://www.google.com/search?q=
Bing News: https://www.bing.com/news/search?q=…
Apple News:
(To view this content, you have to be a subscriber to Apple News+)
https://www.apple.com/apple-news/
Moody’s:
(To view this content, you have to be a subscriber to some of the Moody’s’ Media Solutions (iTopics, NewsEdge oTopics, Closed Content Subscription, Custom Wires, etc.), which syndicates over 25,000 news sources to customers for their internal use or display on their platform)
Moody’s Analytics NewsEdge™
Yahoo Search: http://search.yahoo.com/search?…
Bing Search: http://www.bing.com/search?…
Blogosphere: http://www.blogsearchengine.org/search.html?cx=
Twitter: https://twitter.com/europawire

Facebook: https://www.facebook.com/EuropaWire

Instagram: N/A
G+ https://plus.google.com/+EuropaWire

Google+ (Google Plus) social network has been discontinued for consumers as of April 2, 2019

Pinterest: https://www.pinterest.com/europawire

https://www.pinterest.com/europawire/artificial-intelligence-ai/
https://www.pinterest.com/europawire/european-union/
https://www.pinterest.com/europawire/healthcare/
https://www.pinterest.com/europawire/pharma-biotech/
https://www.pinterest.com/europawire/science/
https://www.pinterest.com/europawire/technology/
https://www.pinterest.com/pin/399413060723951210
https://www.pinterest.com/pin/399413060723951211
https://www.pinterest.com/pin/399413060723951212
https://www.pinterest.com/pin/399413060723951213
https://www.pinterest.com/pin/399413060723951214
https://www.pinterest.com/pin/399413060723951215

Flipboard: https://flipboard.com/@europawire

https://flipboard.com/@europawire/europawire-t5lr53afy
https://flipboard.com/@europawire/apparel%2C-fashion-%26-beauty-74o632aky
https://flipboard.com/@europawire/entertainment-hkhsevd6y
https://flipboard.com/@europawire/healthcare-vkgkndpcy
https://flipboard.com/@europawire/internet-%26-online-enhn8ghjy
https://flipboard.com/@europawire/media-snl3k1aky
https://flipboard.com/@europawire/retail-9qfupsqgy
https://flipboard.com/@europawire/society-g6ovoh9cy

crunchbase:

https://www.crunchbase.com/organization/pandora-project-7398
https://www.crunchbase.com/organization/institut-national-des-sciences-appliqu-es-de-lyon

Paper.li: https://paper.li/e-1431004197
EPR HEALTHCARE NEWS: .

EU Consortium Launches AI‑Driven “Digital Twin” Platform to Transform Aortic Surgery


.

WHO DID WE TARGET…
Countries, markets, verticals, audiences, interests, industries, categories, keywords, tags, etc.
Countries:

Germany (EU)
France (EU)
Italy (EU)
Spain (EU)
Netherlands (EU)
Sweden (EU)
Poland (EU)
Belgium (EU)
Austria (EU)
Denmark (EU)
Finland (EU)
Greece (EU)
Portugal (EU)
Ireland (EU)
Luxembourg (EU)
United Kingdom
Switzerland
Norway

Language: English
Regions, Metros, DMAs, Cities, Towns, etc.: N/A
Industries: Artificial Intelligence (AI), European Union, Healthcare, Pharma & Biotech, Science, Technology, etc.
Markets / Verticals: Aortic Aneurysm, Aortic Surgery, In-Silico Surgery, Cardiovascular Simulation, Digital Twin, Predictive Surgery, MedTech, AI, etc.
Audiences: Internet, search engines and social media users living/residing in France (EU), Germany (EU), Italy (EU), Spain (EU), Netherlands (EU), Sweden (EU), Poland (EU), Belgium (EU), Austria (EU), Denmark (EU), Finland (EU), Greece (EU), Portugal (EU), Ireland (EU), Luxembourg (EU), United Kingdom, Switzerland, Norway using English language and with identified interests like Artificial Intelligence (AI), European Union, Healthcare, Pharma & Biotech, Science, Technology , Aortic Aneurysm, Aortic Surgery, In-Silico Surgery, Cardiovascular Simulation, Digital Twin, Predictive Surgery, MedTech, AI, etc.
Age:
Gender: All
Interests: Artificial Intelligence (AI), European Union, Healthcare, Pharma & Biotech, Science, Technology, Aortic Aneurysm, Aortic Surgery, In-Silico Surgery, Cardiovascular Simulation, Digital Twin, Predictive Surgery, MedTech, AI, etc.
Categories, Keywords, Tags: Artificial Intelligence (AI), European Union, Healthcare, Pharma & Biotech, Science, Technology, 3D models, AIinCardiology, Ansys, Aortic Aneurysms, aortic surgery, AorticAneurysm, AorticSurgery, artificial intelligence, B2B2B approach, biomedical engineer, cardiovascular numerical simulation, Cardiovascular Surgery, CardiovascularHealth, CardiovascularSimulation, Dacron prostheses, datasets, DigitalHealth, DigitalTwin, epidemiological studies, EU-funded, FFplus consortium, H2020 project, HorizonEurope, HPCinHealthcare, In-Silico Modelling, INSA, InSilicoMedicine, InSilicoSurgery, Institut National des Sciences Appliquées, Leonardo Geronzi PhD, LivGemini, LTSI laboratory, Medical Device Manufacturers, medical image analysis, MedicalImageAnalysis, MeDiTATe, MedTechInnovation, mesh morphing algorithms, NumericalSimulation, PANDORA, Pandora Project, PANDORAproject, para-anastomotic aneurysms, post-implant prosthesis kinking, post-surgery coronary perfusion, predictive assessment of aortic surgery outcomes, predictive tools, PredictiveSurgery, prosthesis, RBF Morph, SurgicalPlanning, Université de Rennes, University Hospital of Rennes, UnivREN, etc.
Platforms: Desktop, mobile
WHO DID WE REACH OUT TO…
Total targeted reach, social media reach, followers, subscribers, etc.
Total generic reach: 19,728 people (Jul 7, 2025 – Jul 17, 2025 ~ 11 days)
Total generic video views: 0 people (Jul 7, 2025 – Jul 17, 2025 ~ 11 days)
Total targeted reach: 27,092 people (Jul 7, 2025 – Jul 17, 2025 ~ 11 days)
Total targeted video views: 0 people (Jul 7, 2025 – Jul 17, 2025 ~ 11 days)
Total reach:
(generic + targeted)
46,820 people (Jul 7, 2025 – Jul 17, 2025 ~ 11 days)
Cost per PR total reach: €0.0063
Who did we reach: 27,092+ internet, search engines and social media users living/residing in France (EU), Germany (EU), Italy (EU), Spain (EU), Netherlands (EU), Sweden (EU), Poland (EU), Belgium (EU), Austria (EU), Denmark (EU), Finland (EU), Greece (EU), Portugal (EU), Ireland (EU), Luxembourg (EU), United Kingdom, Switzerland, Norway using English language and with identified interests like Artificial Intelligence (AI), European Union, Healthcare, Pharma & Biotech, Science, Technology , Aortic Aneurysm, Aortic Surgery, In-Silico Surgery, Cardiovascular Simulation, Digital Twin, Predictive Surgery, MedTech, AI, etc.
Combined number of followers the PR reached out to:
(Twitter, FB, G+, incl. re-tweets, likes, shares, etc.)
26,552
Cost per follower reach: €0.011
High profile European influencers reached: 200+

(European/EU politicians, policy makers, government leaders, environmentalists, industrialists, bankers, financiers, c-level execs, top-level managers, professionals, consultants, analysts, investors, high networth individuals, etc.)
Cost per influencer reach: €0.495
Related accounts reached out with your PR message:
(This may also include entities, individuals, accounts, etc. associated with your press release)

PANDORA PROJECT

N/A

LIVGEMINI

https://www.linkedin.com/company/livgemini

FFPLUS CONSORTIUM

linkedin.com/company/43366020
youtube.com/@ffplusproject

RBF MORPH

facebook.com/RBF-Morph-282894151740560/
linkedin.com/company/rbf-morph
twitter.com/RBFMorph
youtube.com/user/RbfMorph

INSA (INSTITUT NATIONAL DES SCIENCES APPLIQUÉES)

facebook.com/insagroupe/
instagram.com/groupeinsa/
linkedin.com/company/groupe-insa
youtube.com/channel/UC4p_z9UyBJv6v65kGL16iqw

UNIVREN (UNIVERSITÉ DE RENNES)

facebook.com/RennesUniv
instagram.com/rennesuniv
linkedin.com/school/rennesuniv
youtube.com/channel/UCAf9V2Z9-gf_Kmbzq-cfljg

LEONARDO GERONZI PHD

linkedin.com/in/leonardo-geronzi/
x.com/GeronziLeonardo
facebook.com/leonardo.geronzi

UNIVERSITY HOSPITAL OF RENNES

youtube.com/channel/UC7MJuq569WFSl-D40zlCvCw
x.com/churennes
linkedin.com/company/36155924/

LTSI LABORATORY

linkedin.com/company/laboratoire-traitement-du-signal-et-de-l-image-ltsi-inserm/

Relevant entities, media outlets, editorial desks, journalists, bloggers, influencers, social media accounts, etc. reached out with your PR message:

// HEALTH, PHARMA, ETC.

ENGLISH LANGUAGE MARKETS (EUROPE)

BBC Health News
The British Medical Journal (BMJ)
The Lancet
Guardian Healthcare
Univadis UK
PulseToday
GPonline.com
HealthServiceJournal
Irish Medical News
Irish Medical Times
Medical Independent
Nursing Times
The Pharmaceutical Journal
Pulse
Healthcare Leader
Pharmaphorum
Digital Health
GP Online
HSJ (Health Service Journal)
MIMS (Monthly Index of Medical Specialities)
British Journal of Healthcare Management
Journal of Health Services Research & Policy
Journal of Medical Ethics
Journal of the Royal Society of Medicine
British Dental Journal
Hospital Times
The Health Foundation Blog
Health Policy Insight
The King’s Fund Blog
Nuffield Trust Blog
BMJ Opinion
National Health Executive
The Health Care Blog
Pharmafield

@bbchealth
@bmj_latest
@bmjdotcom (FB)
@TheLancet
@GdnHealthcare
@univadisUK
@pulsetoday
@PulseToday.co.uk (FB)
@GPonlinenews
@HSJnews
@HSJ.community (FB)
@IMN_doctors
@IMT_latest
@IrishMedicalTimes (FB)
@med_indonews
@nursingtimes
@nursing-times (IN)
@NursingTimesJournal (FB)
@nursingtimes (IG)
@PJOnline_News
@PharmaceuticalJournal (FB)
@the-pharmaceutical-journal (IN)
@pulsetoday
@Pulse-Today-100392502738216 (FB)
@groups/2123632 (IN)
@HCLeaderNews
@Healthcare-Leader-104873128955640 (FB)
@groups/13889750 (IN)
pharmaphorum.com
@pharmaphorum
@pharmaphorum-media (IN)
@pharmaphorum (FB)
digitalhealth.net
@digitalhealth2
@DigitalHealthNews2 (FB)
@digital-health-intelligence-ltd (IN)
gponline.com
@GPonlinenews
@gpwebsite (FB)
hsj.co.uk
@hsjnews
@HSJ.community (FB)
@showcase/28643630 (IN)
mims.co.uk
magonlinelibrary.com/journal/bjhc
journals.sagepub.com/home/hsr
jme.bmj.com
@JME_BMJ
@Journal.of.Medical.Ethics (FB)
journals.sagepub.com/home/jrs
@EditorJRSM
@RoyalSocietyofMedicine (FB)
@royal-society-of-medicine (IN)
@RoyalSocietyMedicine (YT)
nature.com/bdj
hospitaltimes.co.uk
@Hospital_Times
@hospitaltimes (FB)
@hospital-times (IN)
health.org.uk/news-and-comment/blogs
@healthfdn
@thehealthfoundation (FB)
@the-health-foundation (IN)
healthpolicyinsight.com
@HPIAndyCowper
kingsfund.org.uk/blog
@TheKingsFund
@company/52094 (IN)
@thekingsfund (FB)
@kingsfund (YT)
nuffieldtrust.org.uk/research-and-commentary/blog
@nuffieldtrust
@nuffield-trust (IN)
blogs.bmj.com/bmj
nationalhealthexecutive.com
@nhenews
@nationalhealthexecutive (FB)
@nationalhealthnews (IG)
@national-health-executive (IN)
thehealthcareblog.com
@THCBstaff
pharmafield.co.uk
@Pharmafield
@NewPfMag (FB)
@3155781 (IN)

FRENCH LANGUAGE MARKETS (EUROPE)

Egora.fr
JIM.fr
LeQuotidienduMédecin
Le Figaro Santé
Allodocteurs
APMnews.com
HOSPIMEDIA
AP-HP
Le Généraliste
Univadis France
Informations Médicales (BE)
louvainmedical.be
Le Spécialiste (BE)
Journal du Médecin (BE)
Belgian Association of Hospital Managers (BE)
MediQuality.net (BE)
Medi-Sphere Hebdo (BE)
Medi-Sfeer (BE)
Artsenkrant (BE)
#BeHealth (BE)

@Egorafr
@egorafr-130520827015604
@jimweb
@leQdM
@LeFigaro_Sante
@Allodocteurs
@APMinfos
@HOSPIMEDIA
@APHP
@LeGene_hebdo
@univadisFR
louvainmedical.be
@JdS_SK
@jdmedecin
@AbdhBvzd
@MediQuality
@MediSphereHebdo
@MediSfeer
@aktweetsbe
@DigitalHealthBE

GERMAN LANGUAGE MARKETS (EUROPE)

Deutsches Ärzteblatt
Ärzte Zeitung
SPIEGEL ONLINE Gesundheit
FOCUS Gesundheit
SZ Gesundheit
SpringerMedizin.de
Medical Tribune
ots | Gesundheit
MEDIZIN ASPEKTE
deutsche-gesundheits-nachrichten.de
gesundheit.de
PA_Gesundheit
univadis.de
medonline.at (Medizin Medien Austria)
pharmainside.at
MEDIZIN populär (AT)
Medical Tribune (CH)
Schweizerische Ärztezeitung (CH)
Swiss Medical Weekly (CH)
Swiss Medical Forum (CH)
EMH Schweizerischer Ärzteverlag (CH)

@Dt_Aerzteblatt
@aerzteblatt (FB)
@aerztezeitung
@SPIEGEL_Gesund
@focusgesundheit
@SZ_Gesundheit
@SpringerMedizin
@MedTrib_medizin
@ots_gesundheit
@medizinaspekte
@gesundheitd
@gesundheit.de (FB)
@gesundheit-de-701 (xing)
@PA_Gesundheit
@univadis_de
@medonline.at (FB)
@medizinmedienaustria (xing)
@medizinpopulaer (FB)
@MedTribCH
@medicaltribune.ch (FB)
@saez.ch (FB)
@SwissMedicalWeekly (FB)
@SwissMedWkly
@emhmedia (FB)

SPANISH LANGUAGE MARKETS (EUROPE)

EFEsalud
El Mundo Salud
diariomedico
Gaceta Médica
EL GLOBAL
Infosalus
SaluDigital.es
ECSalud.com
Acta Sanitaria
Salud y noticias
Salupedia

@efesalud
@EFEsalud (FB)
@elmundosalud
@diariomedico
@GacetaMedicaCom
@ElGlobalNet
@infosalus_com
@SaluDigital_es
@ECSalud_com
@ActaSanitaria
@noticiasdesalud
@Salupedia

PT

HealthNews.pt
RAIO-X
Saúde Online
News Farma
Notícias Saúde
SNS_Portugal

@healthnews_pt (TW)
@healthnewspt (FB)
@RaioX_pt (TW)
@raiox.pt (FB)
@SaudeonlinePt
@NewsFarma (PT)
@noticiaSaude (FB)
@noticias_saude_oficial (IG)
@SNS_Portugal (TW)

ITALIAN LANGUAGE MARKETS (EUROPE)

Corriere.it Salute
adnkronos.com/Salute
Sole 24 Ore Sanità
Quotidiano Sanità
24salute
MSD Salute
Doctor33
MedicalExcellence.TV
med observer
Saluteuropa
Medicina Moderna
La Nostra Salute

@Corriere_Salute
@adnk_salute
@24OreSanita
@QSanit
@24salute
@msdsalute
@DoctorNews33
@MedexTV
@medlookout
@Saluteuropa
@MedicinaModerna
@LaNostraSalute

DUTCH LANGUAGES MARKETS (EUROPE)

NL

Pharmaceutisch Weekblad (PW)
Farma Actueel
FarmaMagazine
Apothekersnieuws.nl
Apotheek
De Vereniging Innovatieve Geneesmiddelen
De Stichting Farmaceutische Kengetallen (SFK)
De Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie | KNMP
Farma Tweets
Stichting Bedrijfsfonds Apotheken (SBA)
Artsenfederatie KNMG
Medisch Contact
V&VN
Aliëtte Jonkers

@PWnieuws
@farmaactueel
@FarmaMagazine
@Apothekernieuws
@Apothekers
@wewordenbeter
@SFKnieuws
@KNMP
@FarmaTweets
@SBAapotheek
@KNMG
@medischcontact
@VenVN
@aliettejonkers

BE

Informations Médicales (BE)
louvainmedical.be
Le Spécialiste (BE)
Journal du Médecin (BE)
Belgian Association of Hospital Managers (BE)
MediQuality.net (BE)
Medi-Sphere Hebdo (BE)
Medi-Sfeer (BE)
Artsenkrant (BE)
#BeHealth (BE)

@JdS_SK
@jdmedecin
@AbdhBvzd
@MediQuality
@MediSphereHebdo
@MediSfeer
@aktweetsbe
@DigitalHealthBE

NORDIC LANGUAGES MARKETS (EUROPE)

DK

Dagens Medicin
Nicolai Döllner (Chefredaktør for Dagens Medicin)
Lægeforeningen
Ugeskrift for Læger
UgeskriftetVidenskab
DanishMedicinesAgcy
Medicinsk Tidsskrift
min.medicin.dk
pro.medicin.dk
Dagens Pharma
MedWatch

@DagensMedicinDK
@NicolaiDollner
@laegeforeningen
@Ugeskriftet
@UgeskriftetVid
@DKMA_dk
@medicinsktidsskrift (FB)
@Minmedicindk (FB)
@Promedicindk (FB)
@DagensPharma
@MedWatchDK

FI

Terve.fi
Duodecim (Finnish Medical Society)
PotilaanLääkärilehti
Suomen Lääkäriliitto
Lääkärilehti
Mediuutiset
Tehy-lehti

@tervefi
@DuodecimFi
@Potlaakarilehti
@Laakariliitto
@Laakarilehti
@mediuutiset
@Tehylehti

SE

Läkartidningen
Sjukhusläkaren
Läkarförbundet
Dagens Medicin
Vårdfokus
Sjukhusläkarna
DOKTORN.com

@lakartidn
@Sjukhuslakaren
@sjukhuslakaren (FB)
@lakarforbundet
@dagensmedicin
@Vardfokus
@sjukhuslakarna
@doktornpunktcom

NO

Dagens Medisin
Tidsskriftet
Journalen
Sykepleien

@DagensMedisin
@Tidsskriftet
@Journalen
@Sykepleien1

CENTRAL, EASTERN & SOUTHERN EUROPEAN LANGUAGES MARKETS

PL

rynekzdrowia.pl
Wojciech Kuta (Redaktor Rynek Zdrowia)
Portale Medyczne
medexpress.pl
Menedżer Zdrowia
WprostZdrowie
ZdrowieGazeta.pl

@rynekzdrowia
@rynekzdrowia (FB)
@wojciech_kuta
@PortaleMedyczne
@medexpresspl
@MenedzerZdrowia
@WprostZdrowie
@zdrowiewprost (FB)
@zdrowie.gazetapl (FB)

GR

onmed.gr
iatronet.gr
ΙΑΤΡΙΚΟΣ ΤΥΠΟΣ
farmakopoioi
pharmacorner.gr
Vita.gr
Ygeia-News.com

@onmedgr
@onmed.gr (FB)
@iatronet (FB)
@iatronet
@IatrikosTypos
@farmakopoioi
@pharmacorner
@vitagr1 (FB)
@YgeiaNews



(When targeting is too broad — too many countries, audiences, industries and markets are sought after — while the PR budget allocated does not provide the necessary reach and duration of the PR distribution campaign, it becomes nearly impossible to identify the relevant entities to reach out to with your PR message.)

WHO ENGAGED…
PR title views and displays, PR reads, engagements, social media insights, analytics and metrics, mentions, interactions, likes, tweets/retweets, comments, replies, etc.
PR title views/displays:
(generic + targeted)
46,820+ people
PR video views:
(generic + targeted)
0 people
Cost per PR title view: €0.0063
Cost per PR video view: €0.00
PR total reads: 1,319* precisely targeted people read*** your press release
(Jul 7, 2025 – Jul 17, 2025 ~ 11 days**)

* The total PR reads number above is not final. It only covers the observed period for the PR distribution report, which is the active period of your PR campaign, which on itself depends on the PR distribution budget employed. The total number of people who will read your press release is highly likely to increase over time as your press release matures online and becomes more visible in the search engines, the blogoshpere and the social media space as well. Frequent updates are however only done during the active period of your PR distribution campaign, which is correlated to the PR distribution budget you’ve chosen and may be anything between one week and 30+ days with larger PR distribution budgets used. Further updates on this PR distribution report beyond the PR campaign period may be done on an irregular basis. If such an update is made on your PR distribution report in the future, EuropaWire will send a notification on the email address associated with this account.

** The observed period for the PR distribution report is tied up with the PR distribution budget used and covers the active period of your PR distribution campaign. The larger the PR distribution budget the longer both the PR distribution campaign and the observed period covered by your PR distribution report.

*** Read definition: For the sake of the metrics the read is considered and only counted as such, if the following conditions are met: 1) The press release page has fully been loaded in the browser and the time spent on the page by the visitor is at least 30 seconds; 2) An IP address is only counted once per 24 hours regardless how many times the same IP returned on the press release content; 3) Press release content viewed on social media sites do count as reads if and only when there are clear engagements (e.g. likes/loves, tweets, re-tweets, etc.) reported by the respective social media accounts’ metrics and we have an access to and control over those accounts the event/engagement happened on in order to confirm/vitrify; 4) PR title viewed as well as PR title + excerpts viewed, either on the site or on social media accounts and third party sites and places, do NOT count as reads for the purpose of this report; 5) In general and by default press release reads are always more than what we can duly report in our press release distribution reports as we CANNOT gather data for press release content views, reads, mentions, references, etc., on third party sites, social media accounts, private emails and communications (messengers, etc.) that are beyond our control and we have no access to their analytics and metrics; 6) Press release title and content, either partly or in its entirety, displayed, or served to viewers in the form of impressions, either on site, on third party sites or on social media, are not included in the metrics of this report as qualified reads, as we cannot tell how many of those displays/impressions can really be considered as qualified reads (e.g. no reliable data on how long the viewer engaged with the PR content AND/OR not sure whether the viewer was actually interested in what was displayed to her/him). However, it is realistic to assume certain amount of those displays and impressions can also be considered as qualified reads for the metrics of this report. We however, cannot report how many of them qualify as real reads of the press release, hence, do not have them included in this report; 7) And in general all views and reads, having occurred on sites, places and accounts we were not made aware of upon the closure of this PR distribution report are NOT counted and included in as reads; 8) Bots, in any form, type and shape, are by default excluded from the metrics of this report, whenever detected, known and possible.
Cost per PR read: €0.22
PR title views / PR reads ratio: 2.81%
Who read*** your press release: 1,319 precisely targeted individuals living/residing in France (EU), Germany (EU), Italy (EU), Spain (EU), Netherlands (EU), Sweden (EU), Poland (EU), Belgium (EU), Austria (EU), Denmark (EU), Finland (EU), Greece (EU), Portugal (EU), Ireland (EU), Luxembourg (EU), United Kingdom, Switzerland, Norway that speak/read English and are interested in and like Artificial Intelligence (AI), European Union, Healthcare, Pharma & Biotech, Science, Technology , Aortic Aneurysm, Aortic Surgery, In-Silico Surgery, Cardiovascular Simulation, Digital Twin, Predictive Surgery, MedTech, AI, etc.



*** Read definition: For the sake of the metrics the read is considered and only counted as such, if the following conditions are met: 1) The press release page has fully been loaded in the browser and the time spent on the page by the visitor is at least 30 seconds; 2) An IP address is only counted once per 24 hours regardless how many times the same IP returned on the press release content; 3) Press release content viewed on social media sites do count as reads if and only when there are clear engagements (e.g. likes/loves, tweets, re-tweets, etc.) reported by the respective social media accounts’ metrics and we have an access to and control over those accounts the event/engagement happened on in order to confirm/vitrify; 4) PR title viewed as well as PR title + excerpts viewed, either on the site or on social media accounts and third party sites and places, do NOT count as reads for the purpose of this report; 5) In general and by default press release reads are always more than what we can duly report in our press release distribution reports as we CANNOT gather data for press release content views, reads, mentions, references, etc., on third party sites, social media accounts, private emails and communications (messengers, etc.) that are beyond our control and we have no access to their analytics and metrics; 6) Press release title and content, either partly or in its entirety, displayed, or served to viewers in the form of impressions, either on site, on third party sites or on social media, are not included in the metrics of this report as qualified reads, as we cannot tell how many of those displays/impressions can really be considered as qualified reads (e.g. no reliable data on how long the viewer engaged with the PR content AND/OR not sure whether the viewer was actually interested in what was displayed to her/him). However, it is realistic to assume certain amount of those displays and impressions can also be considered as qualified reads for the metrics of this report. We however, cannot report how many of them qualify as real reads of the press release, hence, do not have them included in this report; 7) And in general all views and reads, having occurred on sites, places and accounts we were not made aware of upon the closure of this PR distribution report are NOT counted and included in as reads; 8) Bots, in any form, type and shape, are by default excluded from the metrics of this report, whenever detected, known and possible.

PR shares: 8
PR likes: 248
PR G+: N/A
PR LinkedIn: 0
PR tweets/re-tweets/likes: 256
PR Pinterest: 6
PR Flipboard: 6
PR reactions / comments:
EuropaWire, Search engines, news, Blogosphere, social media, etc.
1

* Please note that PR reactions and comments may happen way beyond the initial active PR distribution campaign period, which is covered by the current PR distribution report and such PR reactions and comments, if any, may be included in future updates on this PR distribution report.
PR mentions:
Third party mentions online as a result of your press release on EuropaWire.
1

* Please note that PR mentions may happen way beyond the initial active PR distribution campaign period, which is covered by the current PR distribution report and such PR mentions, if any, may be included in future updates on this PR distribution report.
INSIGHTS…
PR insights, analyses, rates, averages, conclusions, etc.
Budget vs. target:
Reads vs. target:
Engagement vs. target:
Reach vs. budget:
Reads vs. budget:
Engagement vs. budget:
Reads vs. reach:
Engagement vs. reads:
Engagement vs. reach:
Language vs. target:
Reads vs. language:
Engagement vs. language:
Title vs. audience:
Title vs. target:
Reads vs. title:
EXTEND…
Extend PR distribution campaing to increase reach and engagement, etc.
Extend PR campaign & reach: Based on the PR distribution budget you choose from below, we’ll extend your existing PR distribution campaign for the same press release by using the same settings, preferences, targeting options, etc. The larger the PR distribution budget the longer both the PR distribution campaign and the observed period covered by your PR distribution report.



-END-
GENERAL NOTES:

Should you have any questions about this report, please contact us at info@europawire.eu.Many of the figures, numbers and values included in the PR distribution report above are not final. The current PR distribution report only covers the active period of your PR distribution campaign, which on itself depends on the PR distribution budget employed. Many of the numbers above are highly likely to increase and change over time as your press release matures online and becomes more visible in the search engines, the blogoshpere and the social media space as well. Frequent updates are however only done during the active period of your PR distribution campaign, which is correlated to the PR distribution budget you’ve chosen and may be anything between one week and 30+ days with larger PR distribution budgets used. Further updates on this PR distribution report beyond the PR campaign period may be done on an irregular basis. If such an update is made on your PR distribution report in the future, EuropaWire will send a notification on the email address associated with this account.

Please note that while this PR distribution report is not behind secure page, it is not publicly accessible and unless you give the URL (the web address) away for other people to see it, there is no other way for somebody else to find it out on the Web. No sensitive, private or financial information, if ever made available to us, will ever be published in this report section.

The information in this PR distribution report was factually accurate on the date of its last update (date shown above). This PR distribution report remains on EuropaWire website for historical purposes only. EuropaWire assumes no duty to update the information to reflect subsequent developments beyond the period of the active PR distribution campaign. Readers should not rely upon the information in this PR distribution report as current or accurate after date it was last updated on.

To have an easy and quick access to this report page for further references, please consider bookmarking it.

Thank you for releasing via EuropaWire.

Editorial Staff
EuropaWire